NCT06594029

Brief Summary

The Temple University Collaborative on Community Inclusion (TU Collaborative) is testing a community navigation intervention study based upon effective health navigation models by conducting a randomized controlled trial of the intervention to establish feasibility, efficacy, and outcomes among adults with serious mental illness (SMI).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
74mo left

Started Sep 2024

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Sep 2024Jun 2032

First Submitted

Initial submission to the registry

July 14, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
6.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2032

Expected
Last Updated

September 19, 2024

Status Verified

July 1, 2024

Enrollment Period

11 months

First QC Date

July 14, 2024

Last Update Submit

September 10, 2024

Conditions

Keywords

peer supportcommunity participationSerious Mental Illness

Outcome Measures

Primary Outcomes (2)

  • Temple University Community Participation Scale (TUCP):

    self-reports of community participation in 22 different areas including going to a supermarket, participating in a community social group (like a book club or recreational sports team), going to a movie, or working for pay. Participants are asked to indicate the number of days in the past 30 days that they participated in each of the 22 areas, whether each participation area was important to them, and whether they felt they participated in each area enough, not enough, or too much. Recent research has found the measure to be reliable and valid. An updated version of this measure is included which adds questions related to relationships with intimate partners and children and digital participation.

    baseline, and post-treatment after 6 months

  • WHO Disability Assessment Schedule

    measures each person's capability to participate. It assesses abilities in the areas of cognition, mobility, self-care, life activities, and participation. It contains 15-items.

    baseline, and post-treatment after 6 months

Secondary Outcomes (8)

  • Clinical Assessment Interview for Negative Symptoms

    baseline, and post-treatment after 6 months

  • Assessment Opportunity

    baseline, and post-treatment after 6 months

  • The Social Embeddedness Scale

    baseline, and post-treatment after 6 months

  • Interpersonal Mattering Scale (Moschella & Baynard, 2021; Elliott et al., 2004):

    baseline, and post-treatment after 6 months

  • 3-Item UCLA Loneliness Scale (Hughes, Waite, Hawkley, & Cacioppo, 2004)

    baseline, and post-treatment after 6 months

  • +3 more secondary outcomes

Study Arms (2)

Community Navigator Intervention

EXPERIMENTAL

Weekly meetings between participant and a peer specialist. The peer specialist will help participants identify participation interests, set participation goals, and to achieve those goals while increasing confidence and competence in community participation. Initially, participants will develop a plan for community participation which includes a list of meaningful activities, identifying potential barriers and facilitators to participation. At each weekly meeting, the peer specialist will work with participants to determine what aspects of the plan are working and modify it based on any newly identified barriers, opportunities, or changes to the participants' interests or motivation. The sessions are designed to meet the participants where they are on their journey towards participating in the community. Each successive session will encourage growth and independence through peer support that is tailored to each participant's particular needs and ability.

Behavioral: Community Navigator Intervention

Active control group

ACTIVE COMPARATOR

Receive information on community participation for adults with your health condition

Other: Control Group

Interventions

see previous section

Community Navigator Intervention

Participants receive information on how to increase their community participation

Active control group

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • meet the criteria for an SMI diagnosis of schizophrenia, schizoaffective, bipolar, or major depression diagnosis based on the MINI,
  • are over the age of 18-years-old
  • are fluent in English: As current intervention materials and research and intervention personnel are only fluent in English, only participants who can communicate in written and spoken English are eligible for enrollment.
  • have a permanent residence without constraints on participation (free to come and go from residence without restrictions) 2
  • have the ability to provide informed consent.

You may not qualify if:

  • inability to provide consent (legal guardian)
  • unable to speak and understand English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Social Isolation

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Social BehaviorBehavior

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Central Study Contacts

Bryan Mccormick, PhD

CONTACT

Tabea Neumann, M.Sc.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Data analyst, research assistant conducting research interviews at baseline and post-treatment will be blind to participant allocation
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 14, 2024

First Posted

September 19, 2024

Study Start

September 1, 2024

Primary Completion

August 1, 2025

Study Completion (Estimated)

June 1, 2032

Last Updated

September 19, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

All participants in the study will be required to complete informed consent forms which will include a clause about data preservation and sharing. Subjects will be assured that their identity will be protected and that no personally identifiable information (PII) will be disclosed as part of any data sharing. All data will be stored on Temple University's password protected, HIPAA-approved secure data server. However, because not all investigators who will need access to the data are at Temple, deidentified, anonymized data may be shared with other investigators via a secure file transfer system. All data in the study transferred between Temple University and collaborating institutions will be transferred through TUSafeSend using data encryption by way of a secure socket transfer protocol. TUSafeSend provides a secure method for transferring files containing confidential or other sensitive information, including HIPAA authorized data with PHI or PII.